Neurology Minute
Cost-Effectiveness of Aducanumab
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:02:49
- More information
Informações:
Synopsis
Dr. Brian Callaghan discusses the AAN’s comments at a recent ICER meeting on the cost-effectiveness of aducanumab, the newly approved drug for Alzheimer’s disease.
